<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/bbot" ></link>
<id>urn:uuid:48d71dc7-6d84-f279-2b97-018a10540322</id>
<updated>2026-04-08T08:25:16-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>BBOT: LEBOWITZ PETER F (DIR) Filed a Form 3, Becoming a Registered Insider at BRIDGEBIO ONCOLOGY THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/bbot/bridgebio-oncology-therapeutics-inc/id-6374353" ></link>
<id>urn:uuid:c9d5f376-33cb-a349-c70c-9c67947ae886</id>
<updated>2026-03-26T17:12:54-04:00</updated>
<summary type="html" ><![CDATA[BRIDGEBIO ONCOLOGY THERAPEUTICS INC (BBOT). Recent Price: $8.91. Mkt Cap:713.1mm. 10D Vol: 153,970]]></summary>
</entry>
</feed>